Continuous Liquid–Liquid Extraction of Uranium from Uranium-containing Wastewater Using an Organic Phase-refining-type Emulsion Flow Extractor

International audienc

Self‐Irradiation Damage of a Curium‐Doped Titanate Ceramic Containing Sodium‐Rich High‐Level Nuclear Waste

The polyphase titanate ceramic containing sodium‐rich simulated high‐level nuclear waste was doped with 0.69 wt% of Cm to accelerate long‐term self‐irradiation due to α decays. α autoradiography showed that α emissions were almost uniformaly distributed throughout the curium‐doped samples on a >20‐μm scale although micropore surfaces and titanium oxide agglomerates were free of α‐emitting nuclides. The phase assemblage of the curium‐doped titanate ceramic included freudenbergite and loveringite in addition to the more abundant oxide phases: hollandite, perovskite, and zirconolite. Accumulation of α decays was accompanied by a gradual decrease in density. The increment of density was – 1% after an equivalent age of 5000 yr. Leach tests showed a slight trend toward higher total release of curium with equivalent age. The release of soluble nonradioactive elements (e.g., Na, Cs, Sr, and Ca) in the oldest specimens (equivalent age, 2000 yr) varied from specimen to specimen but, on average, were higher than specimens that had suffered a lower radiation dose

Hokuriku-plus familial hypercholesterolaemia registry study: rationale and study design

Introduction Familial hypercholesterolaemia (FH) is an autosomal-dominant inherited genetic disease. It carries an extremely high cardiovascular risk associated with significantly elevated low-density lipoprotein (LDL) cholesterol. The diagnostic rate of this disease in some European nations is quite high, due to the presence of multiple prospective registries. On the other hand, few data—and in particular multicentre data—exist regarding this issue among Japanese subjects. Therefore, this study intends to assemble a multicentre registry that aims to comprehensively assess cardiovascular risk among Japanese FH patients while taking into account their genetic backgrounds.Methods and analysis The Hokuriku-plus FH registry is a prospective, observational, multicentre cohort study, enrolling consecutive FH patients who fulfil the clinical criteria of FH in Japan from 37 participating hospitals mostly in Hokuriku region of Japan from April 2020 to March 2024. A total of 1000 patients will be enrolled into the study, and we plan to follow-up participants over 5 years. We will collect clinical parameters, including lipids, physical findings, genetic backgrounds and clinical events covering atherosclerotic and other important events, such as malignancies. The primary endpoint of this study is new atherosclerotic cardiovascular disease (ASCVD) events. The secondary endpoints are as follows: LDL cholesterol, secondary ASCVD events and the occurrence of other diseases including hypertension, diabetes and malignancies.Ethics and dissemination This study is being conducted in compliance with the Declaration of Helsinki, the Ethical Guidelines for Medical and Health Research Involving Human Subjects, and all other applicable laws and guidelines in Japan. This study protocol has been approved by the Institutional Review Board at Kanazawa University. We will disseminate the final results at international conferences and in a peer-reviewed journal.Trial registration number UMIN000038210